Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats

Hepatology

Volumn 32, Issue 5, 2000, Pages 980-989

  Qing Wang, Yan ^a   Ikeda, Kazuo ^a   Ikebe, Takashi ^a   Hirakawa, Kosei ^a   Sowa, Michio ^a   Nakatani, Kazuki ^a   Kawada, Norifumi ^a   Kaneda, Kenji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; BROXURIDINE; CARBON TETRACHLORIDE; CYCLIN D1; CYCLIN D2; CYCLIN E; DESMIN; DIMETHYLNITROSAMINE; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; LIVER CELL; LIVER FIBROSIS; MALE; MESENCHYME; NONHUMAN; PRIORITY JOURNAL; RAT; STELLATE CELL;

EID: 0033765497     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.18658     Document Type: Article

References (59)

1. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients
2. Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes); their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs
3. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
4. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells
5. Cytokines and cellular crosstalk involved in the activation of fat-storing cells
6. Morphological aspects of hepatic fibrosis and Ito cells (hepatic stellate cells), with special reference to their myofibroblastic transformation
7. Cellular sources of noncollagenous matrix proteins: Role of fat-storing cells in fibrogenesis
8. Expression of the gene of the α-smooth muscle actin isoform in rat liver and in rat fat-storing (ITO) cells
9. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during culture activation in vivo and in culture
10. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors
11. Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression
12. The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture
13. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ
14. Interferon alpha and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture
15. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis
16. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet
17. Two novel antifibrotics, HOE 077 and safironil, modulate stellate cell activation in rat liver injury
18. Protease inhibitors suppress TGF-β generation by hepatic stellate cells
19. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
20. Inhibitory effect of OPC-15161, a component of fungus Thielavia minor, on proliferation and extracellular matrix production of rat cultured hepatic stellate cells
21. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture
22. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma
23. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis
24. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat
25. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats
26. Hepatocyte growth factor gene therapy of liver cirrhosis in rats
27. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth
28. Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent
29. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470
30. Intra-arterial administration of the angiogenesis inhibitor TNP-470 blocks liver metastasis in a rabbit model
31. Regression of metastatic liver tumors in rats treated with angiogenesis inhibitor TNP-470: Occurrence of apoptosis and necrosis
32. Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats
33. Belotti TNP-470 (AGM-1470): Mechanisms of action early clinical development
34. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo
35. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2
36. Extra-neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver
37. Expression of neural cell adhesion molecule (N-CAM) in perisinusoidal stellate cells of the human liver
38. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells
39. 4 injured rat liver
40. Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis
41. Expression of platelet-derived growth factor in a model of acute liver injury
42. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture
43. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470
44. Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis
45. IPAP: Image processor for analytical pathology
46. Proliferation of Ito cells (fat-storing cells) in acute carbon tetrachloride liver injury. A light and electron microscopic autoradiographic study
47. 4-treated mice. A light and electron microscopic autoradiographic study
48. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
49. Assay of the antiangiogenic compound TNP-470, and one of its metabolites, AGM-1883, by reversed-phase high-performance liquid chromatography in plasma
50. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines
51. Mammalian G1 cyclins
52. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells
53. AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle
54. Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells
55. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinase and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells
56. Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition
57. In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation
58. Cyclins and gap junctions in liver growth and repair
59. Zf9, a Kruppel-like transcription factor up-regulated in vivo during early heaptic fibrosis